Related references
Note: Only part of the references are listed.Short Report: Suspected Yellow Fever Vaccine-Associated Viscerotropic Adverse Events (1973 and 1978), United States
Thomas P. Monath
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity
Thomas P. Monath et al.
VACCINE (2010)
Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study
Elisabeth Schuller et al.
VACCINE (2009)
Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study
E. Schuller et al.
VACCINE (2008)
Adverse event reports following yellow fever vaccination
Nicole P. Lindsey et al.
VACCINE (2008)
Tick-borne encephalitis (TBE) vaccination:: Applying the most suitable vaccination schedule
I. Schoendorf et al.
VACCINE (2007)
Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004
J Hombach et al.
VACCINE (2005)
Share Paper
